Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Grand Shuyang Life Sciences (chengdu) Co., Ltd.

Clinical trials sponsored by Grand Shuyang Life Sciences (chengdu) Co., Ltd., explained in plain language.

Trials to join now! 1

New IVIG treatment aims to boost platelets in ITP patients

Disease control Recruiting now

This Phase 3 trial tests a human immunoglobulin (IVIG) given intravenously for 5 days to adults with chronic immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risk. The study will enroll 36 participants in Turkey to see if the…

Phase: PHASE3 • Sponsor: Grand Shuyang Life Sciences (Chengdu) Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:05 UTC